These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended March 31, 2013
|
||
|
OR
|
||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from to
|
||
|
Delaware
|
33-0264467
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
|
|
30452 Esperanza
|
|
Rancho Santa Margarita, CA 92688
|
|
(Address of principal executive offices, zip code)
|
|
Registrant’s telephone number, including area code:
(949) 635-2100
|
|
Large accelerated filer
|
Accelerated filer
|
Non-accelerated filer
|
Smaller reporting company
ý
|
|
·
|
Our ability to fund our operations in the short and long-term through financing transactions on terms acceptable to us, or at all;
|
|
·
|
Our history of operating losses and the uncertainty surrounding our ability to achieve or sustain profitability;
|
|
·
|
Our limited history of developing and selling products made from our bulk amorphous alloys;
|
|
·
|
Lengthy customer adoption cycles and unpredictable customer adoption practices;
|
|
·
|
Our ability to identify, develop, and commercialize new product applications for our technology;
|
|
·
|
Competition from current suppliers of incumbent materials or producers of competing products;
|
|
·
|
Our ability to identify, consummate, and/or integrate strategic partnerships;
|
|
·
|
The potential for manufacturing problems or delays; and
|
|
·
|
Potential difficulties associated with protecting or expanding our intellectual property position.
|
|
PART I - Financial Information
|
|||
|
Item 1 – Financial Statements
|
4
|
||
|
Consolidated Balance Sheets
|
|||
|
Consolidated Statements of Operations
|
|||
|
Consolidated Statements of Shareholders’ Deficit
|
|||
|
Consolidated Statements of Cash Flows
|
|||
|
Notes to Consolidated Financial Statements
|
|||
|
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
17
|
||
|
Item 3 – Quantitative and Qualitative Disclosures about Market Risk
|
22
|
||
|
Item 4 – Controls and Procedures
|
22
|
||
|
PART II – Other Information
|
|||
|
Item 1 – Legal Proceedings
|
23
|
||
|
Item 1A – Risk Factors
|
23
|
||
|
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds
|
23
|
||
|
Item 3 – Defaults Upon Senior Securities
|
23
|
||
|
Item 4 – Mine Safety Disclosures
|
23
|
||
|
Item 5 – Other Information
|
23
|
||
|
Item 6 – Exhibits
|
24
|
||
|
Signatures
|
25
|
||
|
March 31,
2013
|
December 31,
2012
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
| Assets | ||||||||
|
Current assets:
|
||||||||
|
Cash
|
$ | 5,506 | $ | 7,162 | ||||
|
Trade accounts receivable, net of allowance for doubtful accounts of $14 and $11, respectively
|
123 | 64 | ||||||
|
Prepaid expenses and other current assets
|
637 | 689 | ||||||
|
Total current assets
|
$ | 6,266 | $ | 7,915 | ||||
|
Property and equipment, net
|
181 | 161 | ||||||
|
Patents and trademarks, net
|
840 | 869 | ||||||
| Other assets | 28 | 28 | ||||||
|
Total assets
|
$ | 7,315 | $ | 8,973 | ||||
|
LIABILITIES AND SHAREHOLDERS' DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
81 | 154 | ||||||
|
Accrued liabilities
|
286 | 248 | ||||||
|
Accrued dividends
|
- | 222 | ||||||
|
Deferred revenue
|
5 | - | ||||||
|
Convertible notes, net of debt discount of $2,167 and $4,635, respectively
|
1,833 | 2,365 | ||||||
|
Embedded conversion feature liabilities on convertible notes
|
2,256 | 3,934 | ||||||
|
Total current liabilities
|
$ | 4,461 | $ | 6,923 | ||||
|
Long-term liabilities
|
||||||||
|
Warrant liabilities
|
2,256 | 2,766 | ||||||
|
Other long-term liabilities
|
856 | 856 | ||||||
|
Total liabilities
|
$ | 7,573 | $ | 10,545 | ||||
|
Shareholders' deficit:
|
||||||||
|
Convertible, redeemable Series A Preferred Stock, $0.001 par value; 10,000,000
shares authorized; 0 and 506,936 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively
|
- | - | ||||||
|
Common stock, $0.001 par value; 500,000,000 shares and 400,000,000 authorized
at March 31, 2013 and December 31, 2012, respectively; 305,762,752 and 242,074,324 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively
|
306 | 242 | ||||||
|
Warrants
|
18,179 | 18,179 | ||||||
|
Additional paid-in capital
|
174,635 | 169,891 | ||||||
|
Accumulated deficit
|
(193,378 | ) | (189,884 | ) | ||||
|
Total shareholders' deficit
|
$ | (258 | ) | $ | (1,572 | ) | ||
|
Total liabilities and shareholders' deficit
|
$ | 7,315 | $ | 8,973 | ||||
|
Three Months Ended March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Revenue
|
||||||||
|
Products
|
$ | 117 | $ | 183 | ||||
|
Licensing and royalties
|
5 | 13 | ||||||
|
Total revenue
|
122 | 196 | ||||||
|
Cost of revenue, products
|
82 | 81 | ||||||
|
Gross margin
|
40 | 115 | ||||||
|
Operating expenses
|
||||||||
|
Selling, marketing, general and administrative
|
1,314 | 959 | ||||||
|
Research and development
|
236 | 188 | ||||||
|
Total operating expenses
|
1,550 | 1,147 | ||||||
|
Operating loss
|
(1,510 | ) | (1,032 | ) | ||||
|
Change in value of warrants, gain
|
510 | - | ||||||
|
Change in value of embedded conversion feature liabilities, gain
|
1,678 | - | ||||||
|
Debt discount amortization expense
|
(4,034 | ) | - | |||||
|
Interest expense
|
(141 | ) | (39 | ) | ||||
|
Interest income
|
3 | 4 | ||||||
|
Loss before income taxes
|
(3,494 | ) | (1,067 | ) | ||||
|
Income taxes
|
- | - | ||||||
|
Net loss
|
(3,494 | ) | (1,067 | ) | ||||
|
Per common share basic and diluted:
|
||||||||
|
Loss per share
|
$ | (0.01 | ) | $ | (0.01 | ) | ||
|
Number of weighted average shares
|
282,675,201 | 153,707,246 | ||||||
|
Preferred Shares
|
Common
Shares
|
Common
Stock
|
Warrants part of Additional Paid-in Capital
|
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
|
||||||||||||||||||||||
|
Balance, December 31, 2012
|
506,936 | 242,074,324 | $ | 242 | $ | 18,179 | $ | 169,891 | $ | (189,884 | ) | $ | (1,572 | ) | ||||||||||||||
|
Conversion of preferred stock
|
(506,936 | ) | 16,896,070 | 17 | (17 | ) | - | |||||||||||||||||||||
|
Common stock issuance
|
46,792,358 | 47 | 4,427 | 4,474 | ||||||||||||||||||||||||
|
Stock-based compensation
|
34 | 34 | ||||||||||||||||||||||||||
|
Restricted stock issued to officer
|
78 | 78 | ||||||||||||||||||||||||||
|
Dividend distribution
|
222 | 222 | ||||||||||||||||||||||||||
|
Net loss
|
(3,494 | ) | (3,494 | ) | ||||||||||||||||||||||||
|
Balance, March 31, 2013
|
- | 305,762,752 | $ | 306 | $ | 18,179 | $ | 174,635 | $ | (193,378 | ) | $ | (258 | ) | ||||||||||||||
|
Three Months Ended March 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Operating activities:
|
||||||||
| Net Loss | $ | (3,494 | ) | $ | (1,067 | ) | ||
|
Adjustments to reconcile net loss to net cash provided (used in)
operating activities:
|
||||||||
|
Depreciation and amortization
|
44 | 50 | ||||||
|
Stock-based compensation
|
34 | 102 | ||||||
|
Resticted stock compensation issued to officer
|
78 | - | ||||||
|
Gain from change in value of warrants
|
(510 | ) | - | |||||
|
Gain from change in value of embedded conversion feature liabilities
|
(1,678 | ) | - | |||||
|
Debt discount amortization
|
4,034 | - | ||||||
|
Non-cash interest expense
|
140 | - | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Trade accounts receivable
|
(59 | ) | 47 | |||||
|
Prepaid expenses and other current assets
|
(179 | ) | 71 | |||||
|
Other assets
|
- | 16 | ||||||
|
Accounts payable and accrued expenses
|
(35 | ) | 12 | |||||
|
Deferred revenue
|
5 | (19 | ) | |||||
|
Other liabilities
|
- | 248 | ||||||
|
Net cash used in operating activities
|
(1,620 | ) | (540 | ) | ||||
|
Investing Activities:
|
||||||||
|
Purchases of property and equipment
|
(36 | ) | - | |||||
|
Investment in patents and trademarks
|
- | (35 | ) | |||||
|
Net cash used in investing activities
|
(36 | ) | (35 | ) | ||||
|
Financing Activities:
|
||||||||
|
Proceeds from short-term debt
|
- | 750 | ||||||
|
Net cash provided by financing activities
|
- | 750 | ||||||
|
Net increase (decrease) in cash
|
(1,656 | ) | 175 | |||||
|
Cash at beginning of period
|
7,162 | 122 | ||||||
|
Cash at end of period
|
$ | 5,506 | $ | 297 | ||||
|
Supplemental Schedule of Non-Cash Investing and Financing Activities:
|
||||||||
|
Pre-installment payment of convertible debt through common stock issuance
|
3,120 | - | ||||||
|
Level 1 —
|
Quoted prices in active markets for identical assets or liabilities;
|
|
Level 2 —
|
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
|
|
Level 3 —
|
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
|
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
|
Embedded conversion feature liability
|
- | - | - | $ | 2,256 | |||||||||||
|
Warrant liabilities
|
- | - | $ | 2,256 | - | |||||||||||
|
Convertible Note
|
Debt Discount
|
Net Total
|
||||||||||
|
Beginning Balance - December 31, 2012
|
$ | 7,000 | $ | (4,635 | ) | $ | 2,365 | |||||
|
Installment Payments in Shares
|
(3,000 | ) | - | (3,000 | ) | |||||||
|
Amortization
|
- | 2,468 | 2,468 | |||||||||
|
Ending Balance - March 31, 2013
|
$ | 4,000 | $ | (2,167 | ) | $ | 1,833 | |||||
|
March 31,
2013
|
||||
|
Beginning Balance - January 1, 2013
|
$ | 3,934 | ||
|
Change in value of embedded conversion feature liability, gain
|
(1,678 | ) | ||
|
Ending Balance - March 31, 2013
|
$ | 2,256 | ||
|
Visser MTA
Agreement
|
July 2, 2012
Private Placement
|
Total
|
||||||||||
|
Beginning Balance - December 31, 2012
|
$ | 1,260 | $ | 1,506 | 2,766 | |||||||
|
Change in value of warrant liability, gain
|
(155 | ) | (355 | ) | (510 | ) | ||||||
|
Ending Balance - March 31, 2013
|
$ | 1,105 | $ | 1,151 | $ | 2,256 | ||||||
|
•
|
Revenue recognition
|
|||
|
•
|
Impairment of long-lived assets and definite-lived intangibles
|
|||
|
•
|
Deferred tax assets
|
|||
|
•
|
Valuation of embedded convertible feature liability and warrants
|
|||
|
•
|
Debt discount
|
|||
|
•
|
Share based compensation
|
| For the three months ended March 31, | ||||||||||||||
|
2013
|
2012
|
|||||||||||||
|
in 000's
|
% of Revenue
|
in 000's
|
% of Revenue
|
|||||||||||
|
Revenue
|
(unaudited) | |||||||||||||
|
Products
|
$ | 117 | $ | 183 | ||||||||||
|
Licensing and royalties
|
5 | 13 | ||||||||||||
|
Total revenue
|
122 | 196 | ||||||||||||
|
Cost of revenue
|
82 | 67% | 81 | 41% | ||||||||||
|
Gross margin
|
40 | 33% | 115 | 59% | ||||||||||
|
Selling, marketing, general and administrative
|
1,314 | 1077% | 959 | 489% | ||||||||||
|
Research and development
|
236 | 193% | 188 | 96% | ||||||||||
|
Total operating expense
|
1,550 | 1,147 | ||||||||||||
|
Operating loss
|
(1,510 | ) | (1,032 | ) | ||||||||||
|
Change in value of warrants, gain
|
510 | - | ||||||||||||
|
Change in value of embedded conversion feature liabilities, gain
|
1,678 | - | ||||||||||||
|
Debt discount amortization expense
|
(4,034 | ) | - | |||||||||||
|
Interest expense
|
(141 | ) | (39 | ) | ||||||||||
|
Interest income
|
3 | 4 | ||||||||||||
|
Net loss
|
$ | (3,494 | ) | $ | (1,067 | ) | ||||||||
|
Exhibit
Number
|
Description of Document | |
| 3.1 | Certificate of Incorporation | |
|
31.1
|
Certification of Principal Executive Officer, Thomas Steipp, as required by Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of Principal Financial Officer, Tony Chung, as required by Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32.1
|
Certification of Chief Executive Officer, Thomas Steipp, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
32.2
|
Certification of Chief Financial Officer, Tony Chung, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
101
|
The following financial statements from Liquidmetal Technologies, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 (unaudited), formatted in XBRL: (i) Consolidated Balance Sheets as of March 31, 2013 and December 31, 2012, (ii) Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2013 and 2012, (iii) Consolidated Statement of Shareholders’ Deficit for the three months ended March 31, 2013, (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2013 and 2012, and (v) Notes to Consolidated Financial Statements.
|
|
LIQUIDMETAL TECHNOLOGIES, INC.
|
||
|
(Registrant)
|
||
|
Date: May 14, 2013
|
/s/ Thomas Steipp
|
|
|
Thomas Steipp
|
||
|
President and Chief Executive Officer
|
||
|
(Principal Executive Officer)
|
||
|
Date: May 14, 2013
|
/s/ Tony Chung
|
|
|
Tony Chung
|
||
|
Chief Financial Officer
|
||
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|